BNP Paribas Financial Markets’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $91.1M | Sell |
235,659
-209,798
| -47% | -$77.8M | 0.03% | 483 |
|
|
2026
Q1 | $130M | Sell |
445,457
-8,494
| -2% | -$2.79M | 0.06% | 317 |
|
|
2025
Q4 | $159M | Buy |
453,951
+252,163
| +125% | +$85.2M | 0.07% | 253 |
|
|
2025
Q3 | $65.2M | Sell |
201,788
-131,815
| -40% | -$41M | 0.03% | 515 |
|
|
2025
Q2 | $130M | Sell |
333,603
-76,132
| -19% | -$30.6M | 0.07% | 246 |
|
|
2025
Q1 | $178M | Sell |
409,735
-9,418
| -2% | -$3.78M | 0.1% | 196 |
|
|
2024
Q4 | $155M | Buy |
419,153
+205,491
| +96% | +$86M | 0.09% | 225 |
|
|
2024
Q3 | $111M | Sell |
213,662
-157,738
| -42% | -$84.3M | 0.07% | 253 |
|
|
2024
Q2 | $201M | Buy |
371,400
+23,324
| +7% | +$12.3M | 0.16% | 129 |
|
|
2024
Q1 | $180M | Buy |
348,076
+36,370
| +12% | +$18.1M | 0.16% | 132 |
|
|
2023
Q4 | $147M | Buy |
311,706
+55,250
| +22% | +$25.5M | 0.17% | 139 |
|
|
2023
Q3 | $112M | Buy |
256,456
+19,054
| +8% | +$8.64M | 0.14% | 149 |
|
|
2023
Q2 | $105M | Buy |
237,402
+54,451
| +30% | +$25.1M | 0.13% | 152 |
|
|
2023
Q1 | $84.1M | Buy |
182,951
+103,542
| +130% | +$49.3M | 0.12% | 173 |
|
|
2022
Q4 | $40.7M | Buy |
79,409
+43,436
| +121% | +$22.1M | 0.06% | 383 |
|
|
2022
Q3 | $16.3M | Sell |
35,973
-84,115
| -70% | -$40.2M | 0.03% | 728 |
|
|
2022
Q2 | $58M | Buy |
120,088
+45,608
| +61% | +$22.6M | 0.09% | 246 |
|
|
2022
Q1 | $36.6M | Sell |
74,480
-67,252
| -47% | -$30.7M | 0.05% | 382 |
|
|
2021
Q4 | $65.7M | Buy |
141,732
+47,643
| +51% | +$20M | 0.09% | 228 |
|
|
2021
Q3 | $35.1M | Sell |
94,089
-98,565
| -51% | -$37.5M | 0.05% | 382 |
|
|
2021
Q2 | $73.6M | Buy |
192,654
+151,375
| +367% | +$57.8M | 0.1% | 234 |
|
|
2021
Q1 | $14.8M | Buy |
41,279
+4,020
| +11% | +$1.29M | 0.02% | 655 |
|
|
2020
Q4 | $12M | Sell |
37,259
-256,326
| -87% | -$78.7M | 0.02% | 714 |
|
|
2020
Q3 | $78.9M | Sell |
293,585
-11,977
| -4% | -$3.22M | 0.11% | 176 |
|
|
2020
Q2 | $80.4M | Buy |
305,562
+183,887
| +151% | +$49.1M | 0.14% | 139 |
|
|
2020
Q1 | $27.6M | Buy |
121,675
+29,994
| +33% | +$8.17M | 0.06% | 310 |
|
|
2019
Q4 | $27.7M | Sell |
91,681
-29,014
| -24% | -$7.98M | 0.05% | 393 |
|
|
2019
Q3 | $29M | Sell |
120,695
-42,901
| -26% | -$11.8M | 0.05% | 377 |
|
|
2019
Q2 | $46.2M | Sell |
163,596
-18,183
| -10% | -$4.97M | 0.09% | 235 |
|
|
2019
Q1 | $52.2M | Buy |
181,779
+117,149
| +181% | +$33.9M | 0.11% | 197 |
|
|
2018
Q4 | $17M | Sell |
64,630
-154,339
| -70% | -$42.4M | 0.04% | 470 |
|
|
2018
Q3 | $60M | Sell |
218,969
-80,975
| -27% | -$21M | 0.09% | 226 |
|
|
2018
Q2 | $71.4M | Sell |
299,944
-220,964
| -42% | -$51.2M | 0.12% | 163 |
|
|
2018
Q1 | $114M | Buy |
520,908
+399,278
| +328% | +$93.8M | 0.21% | 87 |
|
|
2017
Q4 | $27.4M | Sell |
121,630
-246,193
| -67% | -$52.4M | 0.05% | 348 |
|
|
2017
Q3 | $69.8M | Buy |
367,823
+211,127
| +135% | +$40.2M | 0.17% | 110 |
|
|
2017
Q2 | $29.5M | Sell |
156,696
-81,063
| -34% | -$14.6M | 0.09% | 228 |
|
|
2017
Q1 | $39.3M | Buy |
237,759
+220,658
| +1,290% | +$35.1M | 0.1% | 185 |
|
|
2016
Q4 | $2.46M | Sell |
17,101
-19,598
| -53% | -$2.62M | 0.01% | 865 |
|
|
2016
Q3 | $4.6M | Sell |
36,699
-8,624
| -19% | -$1.11M | 0.02% | 470 |
|
|
2016
Q2 | $5.95M | Sell |
45,323
-36,982
| -45% | -$5.06M | 0.03% | 421 |
|
|
2016
Q1 | $11.4M | Sell |
82,305
-37,962
| -32% | -$5.07M | 0.05% | 329 |
|
|
2015
Q4 | $16.8M | Sell |
120,267
-36,950
| -24% | -$5.09M | 0.04% | 339 |
|
|
2015
Q3 | $22M | Sell |
157,217
-120,030
| -43% | -$18M | 0.06% | 223 |
|
|
2015
Q2 | $45.5M | Buy |
277,247
+186,129
| +204% | +$29.7M | 0.13% | 100 |
|
|
2015
Q1 | $14.1M | Sell |
91,118
-84,010
| -48% | -$12M | 0.04% | 302 |
|
|
2014
Q4 | $22M | Sell |
175,128
-747,762
| -81% | -$92.4M | 0.08% | 216 |
|
|
2014
Q3 | $110M | Sell |
922,890
-272,506
| -23% | -$31.3M | 0.1% | 119 |
|
|
2014
Q2 | $129M | Sell |
1,195,396
-3,014,867
| -72% | -$311M | 0.12% | 95 |
|
|
2014
Q1 | $606M | Buy |
4,210,263
+3,887,345
| +1,204% | +$352M | 0.47% | 53 |
|
|
2013
Q4 | $29.8M | Sell |
322,918
-105,879
| -25% | -$9.41M | 0.02% | 222 |
|
|
2013
Q3 | $35.9M | Sell |
428,797
-8,398,271
| -95% | -$720M | 0.03% | 225 |
|
|
2013
Q2 | $1.09B | Buy |
+8,827,068
| New | +$661M | 0.77% | 44 |
|
Other funds holding ELV
VCM
VPM
BNP Paribas Financial Markets's ELV Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Elevance Health (ELV) stake by 47% in Q2 2026, selling an estimated $77.8M and leaving 235,659 shares worth $91.1M. The position accounts for 0.03% of the portfolio, ranked #483.
BNP Paribas Financial Markets first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.09B in Q2 2013. 1,303 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- BNP Paribas Financial Markets held 235,659 shares of Elevance Health worth $91.1M as of Q2 2026.
- BNP Paribas Financial Markets sold 209,798 Elevance Health shares in Q2 2026, an estimated $77.8M.
- Elevance Health made up 0.03% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #483 holding.
- BNP Paribas Financial Markets first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- BNP Paribas Financial Markets's Elevance Health position peaked at $1.09B in Q2 2013.
- 1,303 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.